Related Experiment Video
Updated: Jul 15, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
Neoadjuvant use of endocrine therapy in breast cancer
E Jane Macaskill1, J Michael Dixon
1Edinburgh Breast Unit, Western General Hospital, Edinburgh EH4 2XU, United Kingdom.
Abstract:
Neoadjuvant endocrine therapy is becoming increasingly popular as a safe and effective alternative to chemotherapy in selected patients. Large randomized studies have been published comparing tamoxifen with steroidal and nonsteroidal aromatase inhibitors, with favorable results for aromatase inhibitors letrozole, anastrozole, and exemestane. Endocrine therapy can be used in the neoadjuvant setting for conversion of inoperable breast tumors to operable, and from potential mastectomy to breast-conserving surgery. The use of endocrine agents in this setting also provides an opportunity for the study of their biological effects upon tumor.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Endocrine Signaling
Endocrine Signaling
